09 . 12 .2022
News story
Galderma, the pure-play dermatology category leader and maker of Cetaphil, celebrates grand opening of U.S. headquarters in Dallas
16 . 11 .2022
News story
Sales data confirm Galderma’s range of anti-acne products is the No.1 choice globally
17 . 10 .2022
Press release
Galderma launches novel formulation with Alastin Skincare® A-Luminate Brightening Serum® developed to diminish the appearance of hyperpigmentation
13 . 10 .2022
Press release
Galderma announces intention to expand manufacturing and innovation footprint in Asia-Pacific
07 . 10 .2022
News story
Galderma study paves the way for an effective, new acne treatment combination
07 . 10 .2022
Press release
New data from Galderma's aesthetics portfolio to be presented at 2022 ASDS Annual Meeting
03 . 10 .2022
Press release
Galderma and National Breast Cancer Foundation Announce Continued Partnership to Launch Campaign Elevating Skin Stories of Breast Cancer Survivors
16 . 09 .2022
Press release
Galderma debuts the Sensitive Skincare Faculty, a global expert group to improve understanding and management of sensitive skin